Comparison of once daily versus twice daily olmesartan in patients with chronic kidney disease

BACKGROUND: The effects of olmesartan (OLM) on blood pressure and kidney function in Japanese patients with chronic kidney disease (CKD) were compared between 20 mg twice daily (BID) and 40 mg once daily (QD) treatments. METHODS: The subjects were Japanese CKD patients with concurrent hypertension w...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Sakai, Yukinao, Suzuki, Anna, Mugishima, Koji, Sumi, Yuichiro, Otsuka, Yusuke, Otsuka, Tomoyuki, Ohno, Dai, Murasawa, Tsuneo, Tsuruoka, Shuichi
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2013
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3797633/
https://ncbi.nlm.nih.gov/pubmed/24143121
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJNRD.S52905
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki